Analysing the rules of proof in China's first drug patent linkage suit | Managing Intellectual Property
Wu Xiaohui of Wanhuida Intellectual Property explains a pioneering case heard by the Intellectual Property Court of the Supreme People’s Court and considers its implications for original and generic drug makers
Source: managingip.com